Groundbreaking Population Health Strategies for Chronic Kidney Disease

Chronic Kidney Disease (CKD) remains one of the most daunting public health challenges worldwide. With significant comorbidities—such as diabetes, hypertension, and cardiovascular disease—CKD is often both underdiagnosed and under-managed. A proactive chronic kidney disease management strategy within a population health framework can radically change this landscape, improving clinical outcomes and generating much-needed cost savings for health systems. Innovative renal solutions and kidney health interventions are at the forefront of this transformation.

In a recent interview, Cole from the American Journal of Healthcare Strategy spoke with Eric Reimer, an award-winning healthcare entrepreneur, about a groundbreaking approach to managing CKD through population health risk stratification at Healthmap Solutions. Reimer's insights shed light on how technology, kidney disease data analytics, personalized care plans, and targeted collaboration with health plans and providers can yield dramatic benefits for patients with kidney disease.

Defining the Population: "Getting the Right Population"

An essential starting point for any effective chronic kidney disease management strategy is accurately identifying the target group. As Reimer explained: By expanding the lens to include the entire pool of patients who may have CKD (or are at risk of developing it), Reimer's team ensures that they are not missing critical cases. Their approach involves a multi-layered process:

1. Claims and Coding Verification CKD diagnoses may appear in claims data, but not every patient with abnormal labs will carry a formal CKD diagnosis code. Conversely, some patients may be inappropriately coded as having CKD when their condition is only an acute renal issue.
2. Lab Data Analysis Reimer emphasized the importance of laboratory test results, which can reveal objective markers of kidney function. "We do like to look at those lab tests to confirm diagnoses," he said, noting that his team's analytics engine sifts through serum creatinine and estimated glomerular filtration rate (eGFR) data to identify possible CKD cases.
3. Risk Stratification Once a comprehensive population is identified, the next step is to sort them according to their risk of disease progression. "We want to make sure we're prioritizing our efforts," Reimer noted. The most resource-intensive interventions are reserved for higher-risk patients, ensuring better outcomes and cost-effectiveness.

To achieve this, Reimer's team utilizes advanced CKD risk assessment tools and kidney disease data analytics to accurately identify and categorize patients within the population. This process often includes implementing kidney disease screening programs to catch cases early and prevent progression.

Data Acquisition: "At All Costs, We're Trying to Get the Information"

While lab data is crucial for assessing kidney function, obtaining it can be a significant obstacle. Health plans do not always receive comprehensive lab reports, especially if tests are done outside major laboratories like Quest or LabCorp.

Despite these challenges, Healthmap Solutions deploys multiple strategies, including:

• Partnerships with Major Labs and local health information exchanges.
• Provider Collaboration, wherein the physician's office shares lab results.
• Direct Member Engagement, such as asking patients to verbally confirm or share their lab reports.

Crucially, they do not hesitate to order new labs when information is lacking. "If we don't have a lab test," Reimer said, "we get that member to take a lab test." This approach ensures they have the most up-to-date biomarkers and kidney function data for each patient.

In addition to traditional lab work, Reimer's team is exploring the potential of genetic testing and pharmacogenomics to provide more personalized care. These advanced diagnostic tools can help identify patients at higher risk for rapid CKD progression or those who might respond better to certain medications.

Building Personalized Care Plans at Scale

Reimer's model does not merely identify CKD patients—it structures individualized treatment plans tailored to each individual. This requires robust technology and experienced clinicians working in concert:

Key components of these personalized care plans include:

1. Personalized Medication Management Reimer's team verifies prescriptions, checks fill rates, and intervenes if a patient is not taking medications as prescribed—particularly critical for antihypertensives, anti-diabetics, and cholesterol medications that can stabilize CKD progression. This includes specific strategies for managing diabetic kidney disease, which often requires a more nuanced approach.
2. Behavioral Health Screening Many patients with chronic illnesses struggle with depression, anxiety, or other mental health issues. "If appropriate, we'll get them a behavioral health referral," Reimer explained, emphasizing the importance of a holistic approach.
3. Nutritional and Lifestyle Support Because diet, exercise, and stress management dramatically affect CKD progression, individualized goals for nutrition and activity levels are central to the care plan. This includes lifestyle interventions for CKD that are tailored to each patient's needs and preferences, with a focus on proteinuria management, glycemic control, blood pressure control, and lipid management. Dietary adjustments often involve sodium restriction and other specific recommendations based on the stage of kidney disease.
4. Addressing Social Determinants of Health (SDoH) Food insecurity, transportation challenges, and financial hurdles often overshadow even the most robust treatment plan. "We have an attitude on the social determinants of health side, not about identifying [the problem], but really closing the gap," Reimer said. This includes connecting patients with local charities, nonprofits, or government programs to address housing, food, and other basic needs.

Partnering with Providers: "We're Really Trying to Make the Providers… More Effective"

Perhaps the most defining element of Reimer's population health approach is his collaborative stance with providers—both primary care physicians (PCPs) and nephrologists:

Streamlined Collaboration with PCPs

CKD patients can comprise 5–10% of a primary care panel, yet they consume a disproportionate amount of resources. Reimer's team lightens the PCP's burden in several ways:

• Coordinated Communication Each PCP receives targeted insights about their patients—identified through data analytics—rather than broad, generalized advice. "We don't show up there and say, 'We're going to give you information that will be helpful,'" said Reimer. "We say, 'We've identified 16 members in the program that are already seen by you. And let me go through four of them where we think we could make a difference.'"
• Workflow Integration Different practices may prefer different methods of data-sharing—from embedding interventions in electronic medical records (EMRs) to centralized nurse triage. Reimer's team adapts to each practice's workflow to ensure maximum efficiency and minimal duplication.

Bolstering Access to Nephrologists

While PCPs handle preventive measures, nephrologists are vital once CKD has progressed to more advanced stages. Yet nephrologist availability can be limited. Healthmap Solutions approach includes:

• Renal Health Education and Self-Management By conducting thorough patient education sessions, his team reduces nephrologists' need to spend large blocks of time explaining fundamentals. Instead, nephrologists can focus on tasks that only they can perform, such as adjusting complex regimens or assessing suitability for renal replacement therapy options like hemodialysis, peritoneal dialysis, or kidney transplantation.
• Enhanced Data Delivery The program filters massive amounts of claims and lab data into concise, actionable insights. Nephrologists benefit from streamlined data that highlights urgent care gaps—paving the way for more efficient visits and more personalized interventions.

This approach exemplifies integrated nephrology services and the power of multidisciplinary kidney care teams working together to provide comprehensive care. It also facilitates shared decision-making between patients and providers, ensuring that treatment plans align with patient preferences and values.

Innovations in Community Engagement: Lessons from Puerto Rico

A key success story illustrating the unique approach is the organization's expansion into Puerto Rico. Initially advised that it might be challenging to establish a CKD program there due to cultural differences and healthcare system nuances, Reimer decided to go "all in":

This local presence enabled nuanced understanding of cultural practices, regional resource availability, and travel barriers—leading to more targeted interventions:

• Localized Leadership Leaders from each region of Puerto Rico were empowered to make decisions specific to their area. This not only built trust among local patients but also ensured strong ties with local providers and community-based organizations.
• Tailored Social Services By working with local charities and government agencies, the team significantly reduced patients' food and housing insecurities. Transportation services were also arranged to ensure that patients could attend appointments and fill prescriptions promptly.
• Continuity of Care Staff on the island serve as "eyes on the ground," bridging gaps between patients and providers, ensuring that recommended lab work is completed, and helping with any bureaucratic hurdles related to insurance or prescription coverage.

This approach demonstrates the effectiveness of community-based kidney initiatives and patient-centered kidney care in addressing the unique needs of different populations. It also highlights the importance of care navigation in helping patients access appropriate services and adhere to their treatment plans.

Demonstrating Value: "We Are Very, Very Focused on… Outcomes"

Population health initiatives can appear costly at the outset. The real success metric, however, lies in achieving both improved clinical outcomes and lower overall expenditures. Since these efforts ultimately reduce expensive hospitalizations and complications (particularly end-stage renal disease requiring dialysis), they deliver tangible savings for health plans.

Reimer's model operates under performance-based contracts with insurers. In other words, higher rates of medication adherence, fewer emergency admissions, and slower progression of CKD translate to shared savings and financial viability of the program. This alignment ensures that the focus on quality is never sacrificed for short-term cost never sacrificed for short-term cost reductions—addressing the age-old problem in healthcare of balancing care quality with cost efficiency. A population health approach built around comprehensive data collection, patient-centered interventions, and close collaboration with existing providers can revolutionize how chronic kidney disease is managed.

By proactively looking at suspected CKD populations through lab data, comorbidity codes, and claims records, patients receive earlier interventions before costly, preventable complications arise. Care teams engage patients on a personal level, addressing social determinants of health that often stand in the way of consistent medication use and healthy behaviors. Providers work more efficiently and effectively armed with curated data and supported by a team that handles complex patient education and follow-up.

Conclusion

Effective management of chronic kidney disease demands more than sporadic patient check-ins and surface-level data. It requires a comprehensive population health strategy—one that identifies at-risk individuals early, engages them fully, addresses their social and behavioral needs, and collaborates closely with the providers they already trust. In Reimer’s words: “We’re really trying to make the providers that they've already chosen to be more effective.”

By bridging payers, providers, and patients through shared goals and actionable information, this approach paves the way for transformative change in CKD management. The end result: a healthier population, more empowered providers, and a healthcare system better able to deliver both quality and value. For health plans and health systems seeking to implement similar strategies, the lessons are clear. Invest in robust analytics to accurately define and stratify the population. Foster real collaboration with local providers and community resources, especially in regions with unique cultural dynamics. Above all, focus on the entire person’s well-being—from medical adherence to housing and nutrition—because only then can you truly bend the cost curve and improve lives for those living with chronic kidney disease.